Literature DB >> 11163869

The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.

I Nath1, N Vemuri, A L Reddi, S Jain, P Brooks, M J Colston, R S Misra, V Ramesh.   

Abstract

In view of varied reports on the Th1/Th2 paradigm in leprosy, we used a novel real time (RT) fluorogenic reverse transcriptase based PCR (RT-PCR) to measure cytokine expression in peripheral blood cells from lepromatous leprosy patients with stable disease and those suffering from erythema nodosum leprosum (ENL/Type II) reactions. To evaluate the role of accessory cells in Th cell differentiation, co-expression of Th cytokines interferon gamma (IFNgamma) and interleukin (IL) 4 and regulatory cytokines IL 10 and IL 12 was compared in antigen stimulated peripheral blood mononuclear cells (PBMC), cultures containing T cells reconstituted with autologous monocytes (MO) and cultures containing T cells reconstituted with autologous dendritic cells (DC). 7/8 stable lepromatous leprosy patients showed co-expression of both IFNgamma and IL 4, suggesting a Th0 or a combination of Th1 + Th2 subsets in PBMC. The RT-PCR demonstrated that stable lepromatous patients and patients in ENL had significantly higher levels of IFNgamma mRNA molecules compared to IL 4. In fact, 5/8 ENL patients had undetectable levels of IL 4 mRNA, with a skewing of the cytokine response towards a Th1-like profile. Consistent with this. IL 12p40 mRNA molecules were significantly higher in the PBMC of ENL patients compared to stable lepromatous patients (P < 0.01). Reconstitution of purified T cells with autologous DC and MO from the stable lepromatous group resulted in down regulation of IL 4 (P < 0.03 for DC and P < 0.02 for MO) and IL 10 (P < 0. 01 for DC and P < 0.02 for MO), and a consequent skewing towards a Th1 profile similar to that seen in ENL patients. The fact that accessory cells could alter the cytokine profile in the reconstituted cultures suggests that they may play a role in determining Th subset differentiation in chronic diseases, and may influence the immunological stability of such diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11163869     DOI: 10.1016/s0165-2478(00)00271-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  12 in total

Review 1.  Modeling the T cell immune response: a fascinating challenge.

Authors:  Penelope A Morel; James R Faeder; William F Hawse; Natasa Miskov-Zivanov
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-26       Impact factor: 2.745

Review 2.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

3.  The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.

Authors:  J de Souza Sales; F A Lara; T P Amadeu; T de Oliveira Fulco; J A da Costa Nery; E P Sampaio; R O Pinheiro; E N Sarno
Journal:  Clin Exp Immunol       Date:  2011-05-18       Impact factor: 4.330

Review 4.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day.

Authors:  Maria Stella de Mello Ayres Putinatti; Joel Carlos Lastória; Carlos Roberto Padovani
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

6.  On cell signalling mechanism of Mycobacterium leprae soluble antigen (MLSA) in Jurkat T cells.

Authors:  Beenu Joshi; Sihem Khedouci; Pradeep Kumar Dagur; Aziz Hichami; Utpal Sengupta; Naim Akhtar Khan
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

7.  Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Authors:  Karina I Carvalho; Solange Maeda; Luciana Marti; Jane Yamashita; Patrick A J Haslett; Esper G Kallas
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

8.  Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.

Authors:  A Iyer; M Hatta; R Usman; S Luiten; L Oskam; W Faber; A Geluk; P Das
Journal:  Clin Exp Immunol       Date:  2007-11       Impact factor: 4.330

Review 9.  Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease.

Authors:  Jorge Rodrigues de Sousa; Mirian Nacagami Sotto; Juarez Antonio Simões Quaresma
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

10.  Leprosy: an overview of pathophysiology.

Authors:  Ramesh Marne Bhat; Chaitra Prakash
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.